A drug with the SMILES COc1ccc([C@H]2[C@H](C(=O)OC(C)(C)C)N3N=Cc4ccccc4C3C23C(=O)c2ccccc2C3=O)cc1OC has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -3.905%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
COc1ccc([C@H]2[C@H](C(=O)OC(C)(C)C)N3N=Cc4ccccc4C3C23C(=O)c2ccccc2C3=O)cc1OC
COc1ccc([C@H]2[C@H](C(=O)OC(C)(C)C)N3N=Cc4ccccc4C3C23C(=O)c2ccccc2C3=O)cc1OC
tert-butyl (2R,3R)-2-(3,4-dimethoxyphenyl)-1',3'-dioxospiro[3,10b-dihydro-2H-pyrrolo[2,1-a]phthalazine-1,2'-indene]-3-carboxylate